Hillevax

Hillevax Operating Expenses

Delisted

The Total Operating Expenses of Hillevax (HLVX) as of Nov 20, 2026 is 106.96 M USD. In the previous year, Total Operating Expenses was 133.35 M USD — a change of -19.79% (lower).

Operating Expenses

106.96 MUSD

YoY

-19.79%

Last updated:

Total Operating Expenses of Hillevax is 2024 106.96 M USD. Total Operating Expenses of Hillevax was 2023 133.35 M USD. It decreases by -19.79% lower compared to the previous year.

The Hillevax Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2019
633,000.00 USD
Jan 1, 2020
1.30 M USD
Jan 1, 2021
15.77 M USD
Jan 1, 2022
62.61 M USD
Jan 1, 2023
133.35 M USD
Jan 1, 2024
106.96 M USD
The Hillevax Operating Expenses history
YEAROperating ExpensesYoY
106.96 MUSD-19.79%
133.35 MUSD+112.97%
62.61 MUSD+297.04%
15.77 MUSD+1,117.76%
1.30 MUSD+104.58%
633,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

Total Operating Expenses of Hillevax is 106.96 M USD in 2024.

Total Operating Expenses of Hillevax changed from 133.35 M USD to 106.96 M USD, representing a -19.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Hillevax since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Hillevax historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Hillevax

All Key Metrics — Hillevax